Celgene Net Income 2006-2018 | CELG

Celgene annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Celgene net income for the quarter ending September 30, 2018 was $1.082B, a 9.51% increase year-over-year.
  • Celgene net income for the twelve months ending September 30, 2018 was $2.892B, a 16.17% decline year-over-year.
  • Celgene annual net income for 2017 was $2.94B, a 47.07% increase from 2016.
  • Celgene annual net income for 2016 was $1.999B, a 24.78% increase from 2015.
  • Celgene annual net income for 2015 was $1.602B, a 19.9% decline from 2014.
Celgene Annual Net Income
(Millions of US $)
2017 $2,940
2016 $1,999
2015 $1,602
2014 $2,000
2013 $1,450
2012 $1,456
2011 $1,318
2010 $881
2009 $777
2008 $-1,534
2007 $226
2006 $69
2005 $64
Celgene Quarterly Net Income
(Millions of US $)
Q3 2018 $1,082
Q2 2018 $1,045
Q1 2018 $846
Q4 2017 $-81
Q3 2017 $988
Q2 2017 $1,101
Q1 2017 $932
Q4 2016 $429
Q3 2016 $171
Q2 2016 $598
Q1 2016 $801
Q4 2015 $561
Q3 2015 $-34
Q2 2015 $356
Q1 2015 $719
Q4 2014 $614
Q3 2014 $509
Q2 2014 $598
Q1 2014 $280
Q4 2013 $214
Q3 2013 $373
Q2 2013 $478
Q1 2013 $385
Q4 2012 $263
Q3 2012 $424
Q2 2012 $367
Q1 2012 $402
Q4 2011 $410
Q3 2011 $373
Q2 2011 $279
Q1 2011 $256
Q4 2010 $210
Q3 2010 $281
Q2 2010 $155
Q1 2010 $234
Q4 2009 $254
Q3 2009 $217
Q2 2009 $143
Q1 2009 $163
Q4 2008 $-149
Q3 2008 $137
Q2 2008 $120
Q1 2008 $-1,641
Q4 2007 $75
Q3 2007 $39
Q2 2007 $55
Q1 2007 $57
Q4 2006 $23
Q3 2006 $20
Q2 2006 $10
Q1 2006 $16
Q4 2005 $4
Q3 2005 $1
Q2 2005 $11
Q1 2005 $48
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $49.115B $13.003B
Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.059B 13.80
Gilead Sciences (GILD) United States $91.744B 11.05
Biogen (BIIB) United States $64.289B 13.02
Illumina (ILMN) United States $45.743B 53.28
Vertex Pharmaceuticals (VRTX) United States $43.524B 76.03
Regeneron Pharmaceuticals (REGN) United States $36.966B 18.75
Alexion Pharmaceuticals (ALXN) United States $26.441B 18.09
BioMarin Pharmaceutical (BMRN) United States $16.652B 0.00
Incyte (INCY) United States $13.562B 374.88
Seattle Genetics (SGEN) United States $8.782B 0.00
Exact Sciences (EXAS) United States $8.531B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $7.959B 25.45
Sarepta Therapeutics (SRPT) United States $7.803B 0.00
Alnylam Pharmaceuticals (ALNY) United States $6.800B 0.00
Bluebird Bio (BLUE) United States $6.579B 0.00
BeiGene (BGNE) Cayman Islands $6.166B 0.00
Bio-Techne Corp (TECH) United States $6.117B 41.32
Galapagos (GLPG) Belgium $5.266B 0.00
Alkermes (ALKS) Ireland $5.263B 3387.00
Exelixis (EXEL) United States $4.978B 14.11
Amarin (AMRN) Ireland $4.496B 0.00
Horizon Pharma Public (HZNP) Ireland $3.663B 15.07
Immunomedics (IMMU) United States $3.576B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.569B 0.00
Emergent Biosolutions (EBS) United States $3.400B 28.64
Allogene Therapeutics (ALLO) United States $3.192B 0.00
Ligand Pharmaceuticals (LGND) United States $3.155B 24.14
Guardant Health (GH) United States $3.148B 0.00
Array BioPharma (ARRY) United States $3.134B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.987B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.974B 0.00
Repligen (RGEN) United States $2.868B 89.57
Genomic Health (GHDX) United States $2.814B 95.00
Blueprint Medicines (BPMC) United States $2.642B 0.00
Ascendis Pharma (ASND) Denmark $2.564B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.471B 0.00
China Biologic Products (CBPO) China $2.418B 17.22
Allakos (ALLK) United States $2.399B 0.00
Acceleron Pharma (XLRN) United States $2.372B 0.00
Akcea Therapeutics (AKCA) United States $2.333B 0.00
MyoKardia (MYOK) United States $2.279B 0.00
REGENXBIO (RGNX) United States $2.247B 30.14
Myriad Genetics (MYGN) United States $2.242B 22.22
Halozyme Therapeutics (HALO) United States $2.238B 49.94
ACADIA Pharmaceuticals (ACAD) United States $2.228B 0.00
Amicus Therapeutics (FOLD) United States $2.041B 0.00
Global Blood Therapeutics (GBT) United States $1.973B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.893B 0.00
AnaptysBio (ANAB) United States $1.870B 0.00
Reata Pharmaceuticals (RETA) United States $1.823B 0.00
Medicines (MDCO) United States $1.684B 0.00
Aimmune Therapeutics (AIMT) United States $1.666B 0.00
Arena Pharmaceuticals (ARNA) United States $1.662B 0.00
Denali Therapeutics (DNLI) United States $1.640B 0.00
Innoviva (INVA) United States $1.636B 9.25
G1 THERAPEUTICS (GTHX) United States $1.618B 0.00
Spark Therapeutics (ONCE) United States $1.611B 0.00
Atara Biotherapeutics (ATRA) United States $1.587B 0.00
Cambrex (CBM) United States $1.580B 11.80
NeoGenomics (NEO) United States $1.535B 126.92
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.532B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.481B 0.00
Rubius Therapeutics (RUBY) United States $1.390B 0.00
Editas Medicine (EDIT) United States $1.386B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.356B 0.00
IMMURON LTD (IMRN) Australia $1.294B 0.00
Myovant Sciences (MYOV) United Kingdom $1.277B 0.00
Insmed (INSM) United States $1.233B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.223B 0.00
Mirati Therapeutics (MRTX) United States $1.210B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.184B 94.04
WAVE Life Sciences (WVE) Singapore $1.151B 0.00
Solid Biosciences (SLDB) United States $1.132B 0.00
Sangamo Therapeutics (SGMO) United States $1.103B 0.00
Cellectis (CLLS) France $1.071B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.004B 0.00
Audentes Therapeutics (BOLD) United States $1.003B 0.00
Retrophin (RTRX) United States $0.999B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.984B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.979B 0.00
Intra-Cellular Therapies (ITCI) United States $0.947B 0.00
DBV Technologies (DBVT) France $0.943B 0.00
Acorda Therapeutics (ACOR) United States $0.918B 11.63
Alder BioPharmaceuticals (ALDR) United States $0.901B 0.00
UniQure (QURE) Netherlands $0.892B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.891B 0.00
Lion Biotechnologies (IOVA) United States $0.877B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.860B 0.00
Apellis Pharmaceuticals (APLS) United States $0.856B 0.00
Aptinyx (APTX) United States $0.854B 0.00
Fate Therapeutics (FATE) United States $0.844B 0.00
Puma Biotechnology (PBYI) United States $0.841B 0.00
Viking Therapeutics (VKTX) United States $0.824B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.815B 0.00
Clovis Oncology (CLVS) United States $0.804B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.804B 0.00
Revance Therapeutics (RVNC) United States $0.803B 0.00
Intellia Therapeutics (NTLA) United States $0.793B 0.00
Athenex (ATNX) United States $0.779B 0.00
Coherus BioSciences (CHRS) United States $0.758B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
Heska (HSKA) United States $0.742B 60.72
Dynavax Technologies (DVAX) United States $0.739B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.723B 0.00
InflaRx (IFRX) Germany $0.720B 0.00
AVROBIO (AVRO) United States $0.717B 0.00
Vericel (VCEL) United States $0.713B 0.00
TWIST BIOSCIENC (TWST) United States $0.649B 0.00
Novavax (NVAX) United States $0.647B 0.00
UROGEN PHARMA (URGN) Israel $0.646B 0.00
CytomX Therapeutics (CTMX) United States $0.642B 0.00
ANI Pharmaceuticals (ANIP) United States $0.612B 11.73
Gritstone Oncology (GRTS) United States $0.601B 0.00
Epizyme (EPZM) United States $0.600B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.596B 0.00
AC Immune SA (ACIU) Switzerland $0.588B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.587B 0.00
Principia Biopharma (PRNB) United States $0.575B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.567B 0.00
Senesco Technologies (ELOX) United States $0.561B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.560B 0.00
Scholar Rock Holding (SRRK) United States $0.556B 0.00
Arvinas (ARVN) United States $0.549B 0.00
UNITY Biotechnology (UBX) $0.531B 0.00
ObsEva SA (OBSV) Switzerland $0.514B 0.00
Eidos Therapeutics (EIDX) United States $0.510B 0.00
Anika Therapeutics (ANIK) United States $0.509B 21.07
Arcus Biosciences (RCUS) United States $0.495B 0.00
Mesoblast (MESO) Australia $0.480B 0.00
Kezar Life Sciences (KZR) United States $0.478B 0.00
BeyondSpring (BYSI) United States $0.464B 0.00
Inovio Pharmaceuticals (INO) United States $0.461B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.460B 0.00
Prothena (PRTA) Ireland $0.456B 0.00
Kura Oncology (KURA) United States $0.441B 0.00
Sorrento Therapeutics (SRNE) United States $0.435B 71.20
Replimune (REPL) United States $0.432B 0.00
Sinovac Biotech (SVA) China $0.429B 0.00
MediciNova (MNOV) United States $0.426B 0.00
Kindred Biosciences (KIN) United States $0.424B 0.00
PDL BioPharma (PDLI) United States $0.422B 6.88
Zymeworks (ZYME) Canada $0.417B 0.00
Five Prime Therapeutics (FPRX) United States $0.399B 0.00
RA PHARMCTL INC (RARX) United States $0.397B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.384B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.374B 0.00
Zealand Pharma (ZEAL) Denmark $0.374B 0.00
Verastem (VSTM) United States $0.373B 0.00
Stemline Therapeutics (STML) United States $0.372B 0.00
Osiris Therapeutics (OSIR) United States $0.369B 0.00
Abeona Therapeutics (ABEO) United States $0.368B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.366B 0.00
Cytokineticsorporated (CYTK) United States $0.356B 0.00
MeiraGTx Holdings (MGTX) United States $0.344B 0.00
Seres Therapeutics (MCRB) United States $0.331B 0.00
Cellular Biomedicine (CBMG) United States $0.324B 0.00
Merus (MRUS) Netherlands $0.315B 0.00
ResTORbio (TORC) United States $0.310B 0.00
LogicBio Therapeutics (LOGC) United States $0.305B 0.00
Sutro Biopharma (STRO) United States $0.304B 0.00
Liquidia Technologies (LQDA) United States $0.299B 0.00
Albireo Pharma (ALBO) United States $0.299B 0.00
Kodiak Sciences (KOD) United States $0.298B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.297B 0.00
Krystal Biotech (KRYS) United States $0.295B 0.00
Geron (GERN) United States $0.291B 0.00
MannKind (MNKD) United States $0.290B 0.00
Kadmon Holdings (KDMN) United States $0.287B 0.00
Celcuity (CELC) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.265B 0.00
Athersys (ATHX) United States $0.265B 0.00
Arbutus Biopharma (ABUS) Canada $0.265B 0.00
Syros Pharmaceuticals (SYRS) United States $0.262B 0.00
Equillium (EQ) United States $0.260B 0.00
BioDelivery Sciences (BDSI) United States $0.256B 0.00
Aduro Biotech (ADRO) United States $0.254B 0.00
Evelo Biosciences (EVLO) United States $0.246B 0.00
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
TOCAGEN INC (TOCA) United States $0.243B 0.00
Agenus (AGEN) United States $0.239B 0.00
Axovant Sciences (AXON) United Kingdom $0.238B 0.00
ADMA Biologics Inc (ADMA) United States $0.237B 0.00
GAMIDA CELL LTD (GMDA) Israel $0.234B 0.00
Unum Therapeutics (UMRX) United States $0.234B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.233B 0.00
Proteostasis Therapeutics (PTI) United States $0.231B 0.00
Adverum Biotechnologies (ADVM) United States $0.228B 0.00
Magenta Therapeutics (MGTA) United States $0.228B 0.00
Urovant Sciences (UROV) United States $0.222B 0.00
Kala Pharmaceuticals (KALA) United States $0.222B 0.00
BioTime (BTX) United States $0.221B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.220B 0.00
Kamada (KMDA) Israel $0.219B 20.15
Corvus Pharmaceuticals (CRVS) United States $0.212B 0.00
Idera Pharmaceuticals (IDRA) United States $0.207B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.205B 0.00
Protagonist Therapeutics (PTGX) United States $0.202B 0.00
Synlogic (SYBX) United States $0.195B 0.00
Intec Pharma (NTEC) Israel $0.194B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.189B 0.00
ChromaDex (CDXC) United States $0.188B 0.00
NantKwest (NK) United States $0.188B 0.00
Allena Pharmaceuticals (ALNA) United States $0.174B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.172B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.170B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.165B 20.30
Compugen (CGEN) Israel $0.164B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.162B 0.00
Cerecor (CERC) United States $0.157B 0.00
Cohbar (CWBR) United States $0.156B 0.00
Menlo Therapeutics (MNLO) United States $0.156B 0.00
Spero Therapeutics (SPRO) United States $0.154B 0.00
Pfenex (PFNX) United States $0.153B 0.00
Enzo Biochem (ENZ) United States $0.151B 0.00
PSivida (EYPT) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.148B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.145B 0.00
XBiotech (XBIT) United States $0.143B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.141B 0.00
Mersana Therapeutics (MRSN) United States $0.140B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
Eleven Biotherapeutics (SESN) United States $0.131B 0.00
Organovo Holdings (ONVO) United States $0.130B 0.00
Applied Genetic Technologies (AGTC) United States $0.130B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.129B 0.00
OVID THERAPEUTC (OVID) United States $0.127B 0.00
Selecta Biosciences (SELB) United States $0.127B 0.00
Catalyst Biosciences (CBIO) United States $0.125B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
Cue Biopharma (CUE) United States $0.122B 0.00
Mustang Bio (MBIO) United States $0.120B 0.00
Signal Genetics (MGEN) United States $0.112B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.112B 0.00
XOMA (XOMA) United States $0.111B 0.00
Anavex Life Sciences (AVXL) United States $0.111B 0.00
CorMedix Inc (CRMD) United States $0.111B 0.00
Motif Bio Plc (MTFB) United States $0.110B 0.00
Cidara Therapeutics (CDTX) United States $0.108B 0.00
Provention Bio (PRVB) United States $0.102B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.099B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Chiasma (CHMA) United States $0.097B 0.00
ScPharmaceuticals (SCPH) United States $0.095B 0.00
Orgenesis (ORGS) United States $0.091B 0.00
Monster Digital (INNT) United States $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
BioXcel Therapeutics (BTAI) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.086B 0.00
Ophthotech (OPHT) United States $0.084B 0.00
VolitionRX (VNRX) Singapore $0.081B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 90.00
Cel-Sci (CVM) United States $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.076B 0.00
Aptose Biosciences (APTO) Canada $0.076B 0.00
Vaccinex (VCNX) United States $0.075B 0.00
Prima BioMed (IMMP) Australia $0.074B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Aptevo Therapeutics (APVO) United States $0.073B 0.00
VTv Therapeutics (VTVT) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.071B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
ITUS (ANIX) United States $0.069B 0.00
Asterias Biotherapeutics (AST) United States $0.069B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.064B 0.00
Fortress Biotech (FBIO) United States $0.063B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.061B 0.00
VistaGen Therapeutics (VTGN) United States $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.060B 0.00
Sophiris Bio (SPHS) United States $0.060B 0.00
Entera Bio (ENTX) Israel $0.060B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
Bellerophon Therapeutics (BLPH) United States $0.058B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.058B 9.38
Oncobiologics (ONS) United States $0.058B 0.00
Leap Therapeutics (LPTX) United States $0.057B 0.00
Trevena (TRVN) United States $0.055B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
OncoSec Medical (ONCS) United States $0.050B 0.00
Curis (CRIS) United States $0.049B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.049B 0.00
Caladrius Biosciences (CLBS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
TRACON Pharmaceuticals (TCON) United States $0.042B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.042B 0.00
Oncolytics Biotech (ONCY) Canada $0.041B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
AEterna Zentaris (AEZS) United States $0.039B 7.44
Versartis (ARAV) United States $0.039B 6.29
AquaBounty Technologies (AQB) United States $0.039B 0.00
Celsion (CLSN) United States $0.039B 0.00
Galena Biopharma (SLS) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
VIVUS (VVUS) United States $0.035B 0.00
GTx (GTXI) United States $0.035B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
Aileron Therapeutics (ALRN) United States $0.032B 0.00
Proteon Therapeutics (PRTO) United States $0.032B 0.00
Therapix Biosciences (TRPX) Israel $0.029B 10.61
Vical (VICL) United States $0.028B 0.00
Advaxis (ADXS) United States $0.027B 0.00
Eyenovia (EYEN) United States $0.026B 0.00
OvaScience (OVAS) United States $0.025B 0.00
Benitec Biopharma (BNTC) Australia $0.025B 0.00
Cellect Biotechnology (APOP) Israel $0.024B 0.00
CytRx (CYTR) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Pulmatrix (PULM) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Arsanis (ASNS) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
ATyr Pharma (LIFE) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Histogenics (HSGX) United States $0.013B 0.00
Oragenics (OGEN) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Adial Pharmaceuticals (ADIL) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.000B 0.00